PDT Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

PDT Partners’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-31,200	Closed	-$1.29M	–	1804
2015 Q2	$1.29M	Sell	31,200 -7,600	-20%	-$272K	0.03%	658
2015 Q1	$1.37M	Sell	38,800 -1,100	-3%	-$37.2K	0.03%	633
2014 Q4	$1.28M	Buy	39,900 +14,900	+60%	+$431K	0.12%	180
2014 Q3	$702K	Buy	25,000 +3,973	+19%	+$121K	0.02%	831
2014 Q2	$635K	Buy	+21,027	New	+$580K	0.02%	864
2013 Q4	–	Sell	-7,017	Closed	-$210K	–	1447
2013 Q3	$210K	Buy	+7,017	New	+$195K	0.01%	1382

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

PDT Partners's BRLI Position: Q3 2015 in Review

PDT Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 31,200 shares — an estimated $1.29M sold.

PDT Partners first reported a position in BRLI in Q3 2013 and held it in 6 quarters. The position peaked at $1.37M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

PDT Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
PDT Partners sold 31,200 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.29M.
PDT Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 6 quarters.
PDT Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $1.37M in Q1 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.